Detalhe da pesquisa
1.
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
Nat Immunol
; 23(2): 262-274, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35102345
2.
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.
Nat Immunol
; 16(8): 859-70, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26098997
3.
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.
Nat Immunol
; 15(8): 758-66, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24973819
4.
Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors.
EMBO Rep
; 25(3): 1469-1489, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366255
5.
Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization.
Haematologica
; 109(2): 444-457, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534543
6.
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Mol Cancer
; 22(1): 120, 2023 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516818
7.
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
Int J Mol Sci
; 24(8)2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37108755
8.
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers.
Breast Cancer Res
; 24(1): 80, 2022 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401316
9.
Corrigendum: The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.
Nat Immunol
; 16(12): 1292, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26580508
10.
OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients.
BMC Cancer
; 22(1): 41, 2022 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991520
11.
Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series.
Int J Mol Sci
; 23(6)2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35328764
12.
ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer.
Int J Cancer
; 149(1): 200-213, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634878
13.
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.
Mod Pathol
; 34(7): 1282-1296, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753865
14.
Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
Histopathology
; 79(5): 810-825, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121219
15.
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.
Mod Pathol
; 33(6): 1041-1055, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857685
16.
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.
Int J Cancer
; 145(11): 3112-3125, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396953
17.
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Br J Cancer
; 121(3): 283, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31235866
18.
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Br J Cancer
; 119(8): 950-960, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318514
19.
Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
Mod Pathol
; 31(9): 1367-1380, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785016
20.
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells.
J Immunol
; 197(5): 1597-608, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27481844